Interleukin-2 Therapy of Metastatic Renal Cell Carcinoma—Predictors of Response

D MCDERMOTT; M ATKINS

doi:10.1053/j.seminoncol.2006.06.004

Interleukin-2 Therapy of Metastatic Renal Cell Carcinoma—Predictors of Response

Seminars in Oncology ◽

10.1053/j.seminoncol.2006.06.004 ◽

2006 ◽

Vol 33 (5) ◽

pp. 583-587 ◽

Cited By ~ 29

Author(s):

D MCDERMOTT ◽

M ATKINS

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Interleukin 2 ◽

Predictors Of Response

Get full-text (via PubEx)

1255: Potential Role of Postoperative Azotemia in Predicting Response to Interleukin-2 (IL-2) Immunotherapy Following Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(18)31469-1 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 414-414

Author(s):

John S. Lam ◽

Rakhee H. Gael ◽

Tobias Klatte ◽

Fairooz F. Kabbinavar ◽

Arie S. Belldegrun ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Potential Role ◽

Interleukin 2 ◽

Cytoreductive Nephrectomy

Get full-text (via PubEx)

Fas Ligand Expression in Metastatic Renal Cell Carcinoma During Interleukin-2 Based Immunotherapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-1111 ◽

2004 ◽

Vol 10 (23) ◽

pp. 7911-7916 ◽

Cited By ~ 8

Author(s):

Frede Donskov ◽

Hans von der Maase ◽

Niels Marcussen ◽

Stephen Hamilton-Dutoit ◽

Hans Henrik Torp Madsen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Fas Ligand ◽

Interleukin 2 ◽

Ligand Expression

Get full-text (via PubEx)

Recurring cutaneous eruption in a patient with metastatic renal cell carcinoma being treated with high-dose interleukin 2

Journal of the American Academy of Dermatology ◽

10.1067/mjd.2003.204 ◽

2003 ◽

Vol 48 (4) ◽

pp. 602-604 ◽

Cited By ~ 9

Author(s):

Fiona O'Reilly ◽

Elizabeth Feldman ◽

James Yangb ◽

Patrick Hwu ◽

Maria L. Turner

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Interleukin 2 ◽

High Dose ◽

Cutaneous Eruption

Get full-text (via PubEx)

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

Journal of Immunotherapy ◽

10.1097/cji.0000000000000023 ◽

2014 ◽

Vol 37 (3) ◽

pp. 180-186 ◽

Cited By ~ 8

Author(s):

Paul Monk ◽

Elaine Lam ◽

Amir Mortazavi ◽

Kari Kendra ◽

Gregory B. Lesinski ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase I Study ◽

Interleukin 2 ◽

High Dose

Get full-text (via PubEx)

Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells

The Journal of Urology ◽

10.1016/s0022-5347(17)35620-3 ◽

1993 ◽

Vol 150 (3) ◽

pp. 814-820 ◽

Cited By ~ 9

Author(s):

J. Philip Kuebler ◽

Robert P. Whitehead ◽

David L. Ward ◽

George P. Hemstreet ◽

Edward C. Bradley

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Interleukin 2 ◽

Lymphokine Activated Killer Cells ◽

Killer Cells ◽

Recombinant Interleukin 2

Get full-text (via PubEx)

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

ecancermedicalscience ◽

10.3332/ecancer.2016.676 ◽

2016 ◽

Vol 10 ◽

Cited By ~ 2

Author(s):

David M Gill ◽

David D Stenehjem ◽

Kinjal Parikh ◽

Joseph Merriman ◽

Arun Sendilnathan ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Interleukin 2 ◽

High Dose ◽

Conditional Survival

Get full-text (via PubEx)

Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2

Cancer Immunology Immunotherapy ◽

10.1007/s002620050336 ◽

1997 ◽

Vol 43 (5) ◽

pp. 293-298 ◽

Cited By ~ 11

Author(s):

Rutger L. van Bezooijen ◽

H. Goey ◽

Gerrit Stoter ◽

J. Hermans ◽

G. J. Fleuren

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Prognostic Markers ◽

Interleukin 2

Get full-text (via PubEx)

Long term follow up of 50 patients with metastatic renal cell carcinoma treated with high dose i.v. interleukin. 2

European Journal of Cancer ◽

10.1016/s0959-8049(99)81866-8 ◽

1999 ◽

Vol 35 ◽

pp. S358

Author(s):

M. Libra ◽

A. Buonadonna ◽

A. Freschi ◽

A. Bearz ◽

M. Berretta ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Interleukin 2 ◽

High Dose ◽

Long Term Follow Up

Get full-text (via PubEx)

5- fluorouracil blocks T-cell activity during immunochemotherapy in combination with interferon-alpha and interleukin-2 in metastatic renal cell carcinoma

European Urology Supplements ◽

10.1016/s1569-9056(03)80721-2 ◽

2003 ◽

Vol 2 (1) ◽

pp. 182

Author(s):

K. Rohrmann ◽

R. Oberneder ◽

H. Pohla ◽

A. Hofstetter ◽

M. Siebels

Keyword(s):

Renal Cell Carcinoma ◽

T Cell ◽

Cell Carcinoma ◽

Interferon Alpha ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Interleukin 2 ◽

Cell Activity

Get full-text (via PubEx)

STUDY OF ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND INTERLEUKIN-2 FOR METASTATIC RENAL CELL CARCINOMA

The Japanese Journal of Urology ◽

10.5980/jpnjurol1989.84.822 ◽

1993 ◽

Vol 84 (5) ◽

pp. 822-830

Author(s):

Kunio Nomura ◽

Tomoaki Fujioka

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Adoptive Immunotherapy ◽

Renal Cell ◽

Interleukin 2 ◽

Lak Cells

Get full-text (via PubEx)